Matthew Wszolek

3.2k total citations · 2 hit papers
41 papers, 2.0k citations indexed

About

Matthew Wszolek is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Matthew Wszolek has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Matthew Wszolek's work include Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (12 papers) and Renal cell carcinoma treatment (7 papers). Matthew Wszolek is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (12 papers) and Renal cell carcinoma treatment (7 papers). Matthew Wszolek collaborates with scholars based in United States, Canada and Switzerland. Matthew Wszolek's co-authors include Curtis W. Wittmann, Paul M. Salvaterra, Jada Lewis, Mel Β. Feany, Mike Hutton, Joshua M. Shulman, John A. Libertino, Patrick A. Kenney, Justin J. Gould and Adam S. Feldman and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Matthew Wszolek

40 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles

2001 728 citations Matthew Wszolek et al. profile →
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

2017 252 citations Nicholas J. Giacalone, William U. Shipley et al. European Urology profile →

Peers

Countries citing papers authored by Matthew Wszolek

Since Specialization

Citations

This map shows the geographic impact of Matthew Wszolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Wszolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Wszolek more than expected).

Fields of papers citing papers by Matthew Wszolek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Wszolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Wszolek. The network helps show where Matthew Wszolek may publish in the future.

Co-authorship network of co-authors of Matthew Wszolek

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Wszolek. A scholar is included among the top collaborators of Matthew Wszolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Wszolek. Matthew Wszolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance 2025 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), Dimitar V. Zlatev, (unknown), John L. Gore, Douglas M. Dahl, Matthew Wszolek, Jason A. Efstathiou, Richard J. Lee, Michael L. Blute, Keyan Salari, Adam S. Feldman	1
2	A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma 2024 ·BMC Urology ·(unknown), Adam S. Feldman, (unknown), (unknown), (unknown), Matthew Wszolek, Francis J. McGovern, Michael L. Blute, Douglas M. Dahl	1
3	Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy 2023 ·Urologic Oncology Seminars and Original Investigations ·Kendrick Yim, Kevin Melnick, Sarah L. Mott, Filipe L.F. Carvalho, (unknown), Timothy N. Clinton, Matthew Mossanen, Graeme S. Steele, Michelle S. Hirsch, (unknown), Chin‐Lee Wu, Kent W. Mouw, Matthew Wszolek, Keyan Salari, Adam S. Feldman, Adam S. Kibel, Michael A. O’Donnell, Mark A. Preston	14
4	Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series 2022 ·Human Pathology ·Ting Zhao, (unknown), Kristine M. Cornejo, (unknown), Douglas M. Dahl, Matthew Wszolek, Dimitar V. Zlatev, Anthony L. Zietman, Chin‐Lee Wu	5
5	Healthcare Resource Utilization After Surgical Treatment of Cancer: Value of Minimally Invasive Surgery 2022 ·Surgical Endoscopy ·Rocco Ricciardi, Robert N. Goldstone, Todd D. Francone, Matthew Wszolek, Hugh Auchincloss, (unknown), I‐Fan Shih, Yanli Li	8
6	Mortality related to the use of stapler devices and clip appliers: Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience database 2022 ·Surgery ·Balaji Reddy, (unknown), Mark Vangel, (unknown), (unknown), Shirin Razdan, Sanjay Razdan, Matthew Wszolek	1
7	TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer 2020 ·Molecular Cancer Research ·Sharada Mokkapati, Sima P. Porten, Vikram M. Narayan, (unknown), Isuru Jayaratna, Beat Roth, Tiewei Cheng, Neema Navai, Matthew Wszolek, Jonathan Melquist, Ganiraju C. Manyam, Woonyoung Choi, Bradley M. Broom, Shanna Pretzsch, Bogdan Czerniak, David J. McConkey, Colin P. Dinney	6
8	MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER 2019 ·The Journal of Urology ·Nawar Hanna, Matthew Wszolek, Amirkasra Mojtahed, (unknown), Bo Wu, Francisco Gelpi‐Hammerschmidt, Keyan Salari, Douglas M. Dahl, Michael L. Blute, Mukesh G. Harisinghani, Adam S. Feldman	1
9	Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience breakdown → 2017 ·European Urology ·Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, Andrzej Niemierko, Michael Drumm, Niall M. Heney, M. Dror Michaelson, Richard J. Lee, Philip J. Saylor, Matthew Wszolek, Adam S. Feldman, Douglas M. Dahl, Anthony L. Zietman, Jason A. Efstathiou	252
10	Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy 2016 ·European Urology ·Ross Krasnow, Michael Drumm, Hannah Roberts, Andrzej Niemierko, Chin‐Lee Wu, Shulin Wu, Jing Zhang, Niall M. Heney, Matthew Wszolek, Michael L. Blute, Adam S. Feldman, Richard J. Lee, Anthony L. Zietman, William U. Shipley, Jason A. Efstathiou	50
11	Plasma microRNA profiles for bladder cancer detection 2012 ·Urologic Oncology Seminars and Original Investigations ·Liana Adam, Matthew Wszolek, Chang Gong Liu, Jing Wang, Lixia Diao, Alexander Zien, Jitao David Zhang, David A. Jackson, Colin P. Dinney	77
12	The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells 2012 ·Journal of Biological Chemistry ·Mai Tran, Woonyoung Choi, Matthew Wszolek, Neema Navai, (unknown), Giovanni Nitti, Sijin Wen, Elsa R. Flores, Arlene O. Siefker‐Radtke, Bogdan Czerniak, Colin P. Dinney, Michelle Barton, David J. McConkey	109
13	Laparoscopy for the Detection and Treatment of Early Complications from Minimally Invasive Urologic Surgery 2012 ·Journal of Endourology ·Matthew Wszolek, David Canes, Alireza Moinzadeh, Andrea Sorcini	1
14	Nonclamping partial nephrectomy: towards improved nephron sparing 2011 ·Nature Reviews Urology ·Matthew Wszolek, Patrick A. Kenney, John A. Libertino	7
15	Comparison of hilar clamping and non‐hilar clamping partial nephrectomy for tumours involving a solitary kidney 2010 ·British Journal of Urology ·Matthew Wszolek, Patrick A. Kenney, Yoojin Lee, John A. Libertino	53
16	A MicroRNA expression profile defining the invasive bladder tumor phenotype 2009 ·Urologic Oncology Seminars and Original Investigations ·Matthew Wszolek, Kimberly Rieger‐Christ, Patrick A. Kenney, Justin J. Gould, Brasil Silva Neto, (unknown), Tanya Logvinenko, John A. Libertino, Ian C. Summerhayes	105
17	Face, Content, and Construct Validity of dV-Trainer, a Novel Virtual Reality Simulator for Robotic Surgery 2009 ·Urology ·Patrick A. Kenney, Matthew Wszolek, Justin J. Gould, John A. Libertino, Alireza Moinzadeh	147
18	A MICRORNA EXPRESSION PROFILE INVOLVED IN THE INVASIVE BLADDER TUMOR PHENOTYPE 2009 ·The Journal of Urology ·Matthew Wszolek, Justin J. Gould, Patrick A. Kenney, Kimberly Rieger‐Christ, Brasil Silva Neto, (unknown), John A. Libertino, Ian C. Summerhayes	6
19	Surgical management of large renal tumors 2008 ·Nature Clinical Practice Urology ·Matthew Wszolek, Chad Wotkowicz, John A. Libertino	18
20	Resection of Renal Tumors Invading the Vena Cava 2008 ·Urologic Clinics of North America ·Chad Wotkowicz, Matthew Wszolek, John A. Libertino	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact